Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The history shows a new revision entry (v3.3.4) and removal of v3.3.3, which are metadata changes to the record. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:37:21.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the history. These appear to be site maintenance/versioning updates rather than changes to trial data or user-facing functionality.
    Difference
    0.2%
    Check dated 2025-12-23T20:37:29.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Added revision v3.3.2 to the Record History; removed revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:39:44.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The government funding operating-status banner has been removed from the page.
    Difference
    0.6%
    Check dated 2025-11-18T06:54:16.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    No significant changes observed; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T20:58:15.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Added a government operating-status notice and updated version to v3.2.0; removed the previous v3.1.0 reference.
    Difference
    11%
    Check dated 2025-10-06T05:30:59.000Z thumbnail image

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.